Sampre Nutritions LimitedBSE: SAMPRE

Sampre Nutritions Limited Press Release Nov 05 2025

· Issued by Sampre Nutritions Limited via BSE India

Filed with BSE ·

Board Meeting outcome for standalone and consolidated unaudited financial results for the second quarter and half-year ended 30 September 2025; with issuance and allotment of 1770710 equity shares having face value of INR 5 each at an issue price of INR 42 per equity share (including a premium of INR 37 per equity share) aggregating to INR 7,43,69,820 only on preferential basis to promoters for conversion of their existing unsecured loan in the Company.

View Attachment

6ix hasn’t read this filing yet.

Sampre Nutritions Limited on 6ix

Earlier from Sampre Nutritions

Later from Sampre Nutritions

All Sampre Nutritions news releases